Restoring both walking and sensation to patients with paraplegia is an ambitious goal—but a team of researchers from the Keck School of Medicine of USC, the University of California, Irvine (UCI) and ...
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results